Mga Batayang Estadistika
| CIK | 1612630 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to The Joint Corp.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2025 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer of |
|
| August 27, 2025 |
SEPARATION AGREEMENT AND RELEASE Exhibit 10.1 SEPARATION AGREEMENT AND RELEASE This Separation Agreement and Release of Claims (this “Release”) is entered into by and between The Joint Corp., a Delaware corporation with a principal business address at 16767 N. Perimeter Drive, Suite 110, Scottsdale, AZ 85260 (the “Company”), and Jake Singleton, an individual residing at [***] (“Executive”) to be effective as of the date set forth |
|
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: |
|
| August 12, 2025 |
The Joint Corp. Executive Officer Clawback Policy The Joint Corp. Executive Officer Clawback Policy Effective as of December 1, 2023 (the “Adoption Date”) I.Purpose This Executive Officer Clawback Policy describes the circumstances under which Covered Persons of The Joint Corp. and any of its direct or indirect subsidiaries (the “Company”) will be required to repay or return Erroneously-Awarded Compensation to the Company. This Policy and any ter |
|
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| August 12, 2025 |
ASSET PURCHASE AGREEMENT between and among Joint Ventures, LLC, a Nevada limited liability company And The Joint Corp. |
|
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36724 The J |
|
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 001-36724 CUSIP Number: 47973J102 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Trans |
|
| August 7, 2025 |
Exhibit 99.1 The Joint Corp. Reports Second Quarter 2025 Financial Results - Refranchised 37 clinics; Franchises now represent 92% of the portfolio - - Acquired rights to the Northwest regional developer territory - SCOTTSDALE, Ariz., August 7, 2025 – The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, posted operating highlights and limited financ |
|
| August 7, 2025 |
a25-08x07jyntq22025final NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. Q2 2025 Financial Results As of June 30, 2025, reported August 7, 2025 1 NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. Safe Harbor Statements Certain statements contained in this presentation are "forward-looking statements." We have tried to identify these forward-looking statements by using words suc |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer of |
|
| July 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2025 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer of i |
|
| July 30, 2025 |
Exhibit 99.1 The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges - Expects to reduce 2024 net loss and increase carrying value of assets held for sale by approximately $2.2 million - - Expects to increase first quarter 2025 net income by approximately $0.5 million, resulting in a cumulative increase in carryi |
|
| July 7, 2025 |
Exhibit 99.1 The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region - Proven Operator Grows to 96 Clinics and Commits to Open 10 Additional Clinics - - Sale Price Included $8.3 Million Plus Regional Developer Rights that Generated $855,000 in Royalties and Franchise Fees over the 12 Months Ended March 31, 2025 - |
|
| July 7, 2025 |
The Joint Corp. Unaudited Pro Forma Condensed Consolidated Financial Information Exhibit 99.2 The Joint Corp. Unaudited Pro Forma Condensed Consolidated Financial Information On June 23, 2025, we entered into an Asset Purchase Agreement with Joint Ventures, LLC, a Nevada limited liability company and our largest franchisee (“Joint Ventures”), pursuant to which we agreed to sell to Joint Ventures the assets of, and grant franchise rights to, 31 company-owned and managed clinics |
|
| July 7, 2025 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer of i |
|
| June 27, 2025 |
Exhibit 99.1 The Joint Corp. Signs Binding Agreement to Sell 31 Corporate Clinics in Arizona and New Mexico and to Acquire Regional Developer Rights in the Northwest Region and Refranchises Five Corporate Clinics in the Kansas City Region, Tracking to Become Largest Pure Play Chiropractic Care Franchise System - The Joint to Deploy Capital and Enhance Profitability Profile by Reducing Regional Dev |
|
| June 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2025 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer of i |
|
| June 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2025 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer of in |
|
| June 10, 2025 |
The Joint Corp. Names Business Transformation and Growth Expert Scott J. Bowman Chief Financial Officer - Public and private company CFO with 30 years’ experience in restaurants, retail and CPG – SCOTTSDALE, Ariz., June 10, 2025 – The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced Scott J. Bowman joined as Chief Fin |
|
| June 10, 2025 |
Employment Agreement, dated June 10, 2025, by and between the Registrant and Scott J. Bowman ACTIVE 702119151v3 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is entered into by and between The Joint Corporation, a Delaware corporation (the “Company”) and Scott Bowman (“Executive”) as of June 10, 2025 to be effective as of the Effective Date (as defined herein). |
|
| June 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2025 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer of in |
|
| June 5, 2025 |
1 The Joint Corp. Announces $5 Million Stock Repurchase Program SCOTTSDALE, Ariz., June 5, 2025 – The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that its board of directors has authorized a stock repurchase program expected to begin in August 2025 under which the company may repurchase up to $5 million of its ou |
|
| June 5, 2025 |
a99125-06x04jyntbodkarrm 1 The Joint Corp. Appoints Sandi Karrmann as Director - Accomplished Global HR Executive with Deep Franchise and Healthcare Expertise, including CHRO Roles at Kimberly-Clark, Tenet Healthcare, and Yum! Restaurants International, to Join Board - SCOTTSDALE, Ariz., June 4, 2025 – The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The J |
|
| May 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 21, 2025 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) (Commission file numbe |
|
| May 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| May 8, 2025 |
99.1 The Joint Corp. Reports First Quarter 2025 Financial Results - Grew revenue from continuing operations 7% compared to Q1 2024 - - Increased system-wide sales 5% for Q1 2025, demonstrating economic resilience - SCOTTSDALE, Ariz., May 8, 2025 – The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter end |
|
| May 8, 2025 |
NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. Q1 2025 Financial Results As of March 31, 2025, reported May 8, 2025 1 NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. Safe Harbor Statements Certain statements contained in this presentation are "forward-looking statements." We have tried to identify these forward-looking statements by using words such as "may," "might," " will |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer of inc |
|
| April 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ☒ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Fee paid previously with preliminary materials.Confidential, for Use of the Commission Only (as permitte |
|
| April 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ☒ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Fee paid previously with preliminary materials.Confidential, for Use of the Commission Only (as permitte |
|
| March 14, 2025 |
Insider trading policies and procedures Exhibit 19.1 Insider Trading Policy Introduction This Insider Trading Policy (the “Policy”) provides guidelines to employees, officers and directors of The Joint Corp. (the “Company” or “The Joint”) with respect to transactions in the Company’s securities. The Company has adopted this policy and the procedures set forth herein to help prevent insider trading and to assist the Company’s employees, |
|
| March 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36724 The Joint Corp. (Exact na |
|
| March 14, 2025 |
Executive Short-Term Incentive Plan (STIP) (Amended March 10, 2025) Exhibit 10.51 The Joint Corp. Executive Short-Term Incentive Plan (STIP) (Amended and Restated March 10, 2025) Plan Summary The Joint Corp. (“the Company”) Executive Short-Term Incentive Plan (“Executive STIP”) is an annual bonus plan. The Executive STIP Pool earned for each year will be determined based on achievement against metrics (the “STIP Metrics”) established by the Compensation Committee |
|
| March 14, 2025 |
Form of Restricted Stock Award (The Joint Corp. 2024 Incentive Stock Plan) Exhibit 10.43 [[FIRSTNAME]] [[MIDDLENAME]] [[LASTNAME]] Restricted Stock Award (The Joint Corp. 2024 Incentive Stock Plan) Subject to the following terms, The Joint Corp., a Delaware corporation (the Company), grants to the following employee of the Company (Grantee), as of the following grant date (the Grant Date), the following number of restricted shares (the Restricted Shares), which will beco |
|
| March 14, 2025 |
Exhibit 10.42 [[FIRSTNAME]] [[MIDDLENAME]] [[LASTNAME]] NSO Stock Option Agreement (Nonstatutory Stock Option Granted Under The Joint Corp. 2024 Incentive Stock Plan) Subject to the following terms, The Joint Corp., a Delaware corporation (the Company), grants to the following employee of the Company (Grantee), as of the following grant date (the Grant Date), an nonstatutory stock option (the Opti |
|
| March 14, 2025 |
Executive Short-Term Incentive Plan (STIP) (Amended March 10, 2025) Exhibit 10.44 Confidentiality and Nonsolicitation Agreement This Confidentiality and Nonsolicitation Agreement (this Agreement) is entered into by The Joint Corp., a Delaware corporation and [name of employee], an employee of the Company (Employee), as of , 20. Background: The Company has granted to Employee an award (the Award) under The Joint Corp. 2024 Incentive Stock Plan (the Plan). As a cond |
|
| March 14, 2025 |
Exhibit 10.41 [[FIRSTNAME]] [[MIDDLENAME]] [[LASTNAME]] ISO Stock Option Agreement (Incentive Stock Option Granted Under The Joint Corp. 2024 Incentive Stock Plan) Subject to the following terms, The Joint Corp., a Delaware corporation (the Company), grants to the following employee of the Company (Grantee), as of the following grant date (the Grant Date), an incentive stock option (the Option) to |
|
| March 13, 2025 |
99.1 The Joint Corp. Reports Fourth Quarter and Year-end 2024 Financial Results - Grew revenue from continuing operations 10% annually and 14% quarterly compared to the same period in 2023 - - Increased system-wide sales 9% for both the year and Q4 2024 – SCOTTSDALE, Ariz., March 13, 2025 – The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, report |
|
| March 13, 2025 |
NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. Q4 2024 Financial Results As of December 31, 2024, reported March 13, 2025 1 Exhibit 99.2 NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. Safe Harbor Statements Certain statements contained in this presentation are "forward-looking statements." We have tried to identify these forward-looking statements by using words such as "ma |
|
| March 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2025 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer of |
|
| January 16, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2025 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| January 16, 2025 |
EXHIBIT 99.1 The Joint Corp. Reports 2024 Operating Metrics - Adjustments Performed in 2024 Grows 9%, Compared to 2023 - - Receives Letters of Intent for the majority of the Corporate Portfolio in Early January 2025 - SCOTTSDALE, Ariz., Jan. 16, 2025 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, provided operating metrics f |
|
| December 23, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2024 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| December 23, 2024 |
Exhibit 10.1 Section 1. AMENDED AND RESTATED NOMINATION AND STANDSTILL AGREEMENT This Amended and Restated Nomination and Standstill Agreement (as the same may be amended, this “Agreement”), dated as of December 19, 2024 (the “Effective Date”), is by and among The Joint Corp., a Delaware corporation (the “Company”), and the Persons (as defined below) set forth on the signature pages hereto |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The J |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer o |
|
| November 7, 2024 |
Q3 2024 Results As of Sept. 30, 2024 | Reported on Nov. 7, 2024 99.2 Safe Harbor Statements Certain statements contained in this presentation are "forward-looking statements” about future events and expectations. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth plans, taking into acco |
|
| November 7, 2024 |
The Joint Corp. Reports Third Quarter 2024 Financial Results 99.1 The Joint Corp. Reports Third Quarter 2024 Financial Results SCOTTSDALE, Ariz., November 7, 2024 – The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter ended September 30, 2024. Financial Highlights: Q3 2024 Compared to Q3 2023 ●Grew revenue 2% to $30.2 million. ●Reported net loss of $3.2 million, |
|
| October 15, 2024 |
Exhibit 10.4 Sanjiv Razdan NSO Stock Option Agreement (Nonstatutory Stock Option Inducement Award) Subject to the following terms, The Joint Corp., a Delaware corporation (the Company), grants to the following employee of the Company (Grantee), as a material inducement to, and in connection with, Grantee’s acceptance of an offer of employment with the Company, as of the following grant date (the G |
|
| October 15, 2024 |
Exhibit 10.5 Confidentiality and Nonsolicitation Agreement This Confidentiality and Nonsolicitation Agreement (this Agreement) is entered into by The Joint Corp., a Delaware corporation and Sanjiv Razdan , an employee of the Company (Employee), as of October 14, 2024. Background: The Company has granted to Employee an award (the Award) granted outside the terms of The Joint Corp. 2024 Incentive St |
|
| October 15, 2024 |
Exhibit 10.1 SEPARATION AGREEMENT AND RELEASE This Separation Agreement and Release of Claims (this “Release”) is entered into by and between The Joint Corporation (the “Company”), and Peter D. Holt (“Executive”) to be effective as of the date set forth next to Executive’s signature below (the “Effective Date”). Executive and the Company are occasionally referred to herein as a “Party” or the “Par |
|
| October 15, 2024 |
EXHIBIT 99.1 The Joint Corp. Appoints Sanjiv Razdan President and Chief Executive Officer -Seasoned Franchise Executive to also Join the Company’s Board of Directors- SCOTTSDALE, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation’s largest franchisor of chiropractic care through The Joint Chiropractic® network, welcomes Sanjiv Razdan as |
|
| October 15, 2024 |
The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) EXHIBIT 99.2 The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation’s largest franchisor of chiropractic care through The Joint Chiropractic® network, today announced that it granted equity awards on October 14, 2024 as a material inducement to the |
|
| October 15, 2024 |
Employment Agreement, dated October 14, 2024, by and between the Registrant and Sanjiv Razdan Exhibit 10.2 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is entered into by and between The Joint Corporation, a Delaware corporation (the “Company”) and Sanjiv Razdan (“Executive”) as of October 14, 2024 to be effective as of the Effective Date (as defined herein). In this Agreement, the Company and Executive are occasionally referred to herein as a “party” or “the parties.” |
|
| October 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2024 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| October 15, 2024 |
Exhibit 10.3 Sanjiv Razdan Restricted Stock Award (Inducement Award) Subject to the following terms, The Joint Corp., a Delaware corporation (the Company), grants to the following employee of the Company (Grantee), as a material inducement to, and in connection with, Grantee’s acceptance of an offer of employment with the Company, as of the following grant date (the Grant Date), the following numb |
|
| August 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| August 8, 2024 |
Q2 2024 Financial Results As of June 30, 2024 | Reported on August 8, 2024 99.2 Safe Harbor Statements Certain statements contained in this presentation are "forward-looking statements” about future events and expectations. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth plans, takin |
|
| August 8, 2024 |
99.1 The Joint Corp. Reports Second Quarter 2024 Financial Results - Grew Q2 2024 Revenue 3%, System-wide Sales 8% and System-wide Comp Sales 2% vs. Q2 2023 - - Increased Clinic Count to 960 at June 30, 2024 - SCOTTSDALE, Ariz., August 8, 2024 – The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter ended |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer of |
|
| May 29, 2024 |
The Joint Corp. 2024 Incentive Stock Plan Exhibit 10.1 The Joint Corp. 2024 Incentive Stock Plan Article 1 Purpose The purpose of this plan is to recognize and reward participants for their efforts on the Company’s behalf, to motivate participants by appropriate incentives to contribute to the Company’s attainment of its performance objectives, and to align participants’ interests with those of the Company’s other stockholders through com |
|
| May 29, 2024 |
As filed with the Securities and Exchange Commission on May 29, 2024 As filed with the Securities and Exchange Commission on May 29, 2024 Registration No. |
|
| May 29, 2024 |
Exhibit 107 Calculation of Filing Fee Table S-8 (Form Type) The Joint Corp. (Exact Name of Registrant as Specified in its Charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price (2) Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.0 |
|
| May 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 22, 2024 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission file number) (IRS employer o |
|
| May 24, 2024 |
The Joint Corp. 2024 Incentive Stock Plan Exhibit 10.1 The Joint Corp. 2024 Incentive Stock Plan Article 1 Purpose The purpose of this plan is to recognize and reward participants for their efforts on the Company’s behalf, to motivate participants by appropriate incentives to contribute to the Company’s attainment of its performance objectives, and to align participants’ interests with those of the Company’s other stockholders through com |
|
| May 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| May 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| May 2, 2024 |
EXHIBIT 99.1 The Joint Corp. Reports First Quarter 2024 Financial Results - Grew Q1 2024 Revenue 5%, System-wide Sales 9%, and System-wide Comp Sales 3% vs. Q1 2023 - - Opened 23 Franchised Clinics, Increasing Clinic Count to 954 at March 31, 2024 - - Sold 15 Franchise Licenses, Tripling Sales Compared to Q4 2023 - SCOTTSDALE, Ariz., May 2, 2024 – The Joint Corp. (NASDAQ: JYNT), a national operato |
|
| May 2, 2024 |
Q1 2024 Financial Results As of March 31, 2024 | Reported on May 2, 2024 EXHIBIT 99. |
|
| May 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2024 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer of inc |
|
| April 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| March 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36724 The Joint Corp. (Exact na |
|
| March 7, 2024 |
EXHIBIT 99.2 Q4 2023 Financial Results As of December 31, 2023 | Reported on March 7, 2024 Exhibit 99.2 Safe Harbor Statements Certain statements contained in this presentation are "forward - looking statements” about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance |
|
| March 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2024 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| March 7, 2024 |
EXHIBIT 99.1 The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results - Grew 2023 Revenue 16%, System-wide Sales 12%, and System-wide Comp Sales 4% vs. 2022 - - Increased Clinic Count to 935 at Year-end 2023, Initiating Refranchising Program - SCOTTSDALE, Ariz., March 07, 2024 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiro |
|
| February 13, 2024 |
JYNT / The Joint Corp. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01258-jointcorpthe.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Joint Corp/The Title of Class of Securities: Common Stock CUSIP Number: 47973J102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the ru |
|
| January 12, 2024 |
JYNT / The Joint Corp. / MILLENNIUM MANAGEMENT LLC Passive Investment SC 13G/A 1 JYNTSC13GA1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) THE JOINT CORP. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 47973J102 (CUSIP Number) DECEMBER 31, 2023 (Date of event which requires filing of this statement) Check the appropriate bo |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The J |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2023 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| November 9, 2023 |
EXHIBIT 99.2 Q3 2023 Financial Results As of September 30, 2023 | Reported on November 9, 2023 The Joint Corp. | NASDAQ: JYNT | thejoint.com EXHIBIT 99.2 Safe Harbor Statements © 2023 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements” about future events and expectations. Forward - looking statements are based on our beliefs, |
|
| November 9, 2023 |
EXHIBIT 99.1 The Joint Corp. Reports Third Quarter 2023 Financial Results - Reaffirms 2023 Financial and Clinic Opening Guidance - - Unveils Plan to Convert the Majority of the Corporate Portfolio Clinics to Franchised Clinics - SCOTTSDALE, Ariz., November 9, 2023 – The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results |
|
| November 8, 2023 |
JYNT / Joint Corp / Bandera Partners LLC - AMENDMENT NO. 3 TO THE SCHEDULE 13D Activist Investment SC 13D/A 1 sc13da30870601311082023.htm AMENDMENT NO. 3 TO THE SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 3)1 The Joint Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Cl |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2023 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or other jurisdiction (Commission File Number) (IRS Employer o |
|
| November 8, 2023 |
EXHIBIT 10.2 CONFIDENTIALITY AGREEMENT November 6, 2023 Bandera Master Fund L.P. 50 Broad Street, Suite 1820 New York, New York 10004 Attention: Jefferson Gramm Dear Mr. Gramm: Reference is made to the Nomination and Standstill Agreement (as the same may be amended, the “Nomination and Standstill Agreement”), dated as of November 6, 2023, by and among The Joint Corp., a Delaware corporation (toget |
|
| November 8, 2023 |
Nomination and Standstill Agreement, dated November EXHIBIT 10.1 NOMINATION AND STANDSTILL AGREEMENT This Nomination and Standstill Agreement (as the same may be amended, this “Agreement”), dated as of November 6, 2023 (the “Effective Date”), is by and among The Joint Corp., a Delaware corporation (the “Company”), and the Persons (as defined below) set forth on the signature pages hereto (collectively “Bandera”). Capitalized terms used in this Agre |
|
| November 8, 2023 |
EXHIBIT 99.1 The Joint Corp. Welcomes Jeff Gramm to the Board of Directors and Signs Standstill Agreement with Bandera Partners LLC SCOTTSDALE, Ariz., November 8, 2023 – The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network, will appoint Jeff Gramm to the board of directors, effective January 2, 2024 and nominate him for election |
|
| November 8, 2023 |
NOMINATION AND STANDSTILL AGREEMENT EX-99.1 2 ex991to13da308706013110823.htm NOMINATION AND STANDSTILL AGREEMENT, DATED NOVEMBER 6, 2023 Exhibit 99.1 NOMINATION AND STANDSTILL AGREEMENT This Nomination and Standstill Agreement (as the same may be amended, this “Agreement”), dated as of November 6, 2023 (the “Effective Date”), is by and among The Joint Corp., a Delaware corporation (the “Company”), and the Persons (as defined below) |
|
| October 30, 2023 |
Executive Short-Term Incentive Plan (STIP) (Amended March 7, 2023) 10.16 The Joint Corp. Executive Short-Term Incentive Plan (STIP) (Amended March 7, 2023) Plan Overview The Joint Corp. (“the Company”) Executive Short-Term Incentive Plan (“Executive STIP”) is an annual bonus plan. The STIP pool earned for each year will be determined based upon the achievement of the Company’s Target EBITDA for that year. Upon achievement of the Target EBITDA for the calendar yea |
|
| October 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joi |
|
| September 26, 2023 |
Form of the Registrant’s Franchise Agreement. 10.25 THE JOINT CORP. FRANCHISE AGREEMENT TABLE OF CONTENTS SECTION PAGE TOC \h \u \z 1. INTRODUCTION……………………………………………………………………………………4 2. GRANT OF FRANCHISE…………………………………………………………………………...5 2.1 Term; Reference to Exhibit 1………………………………………………………………………5 2.2 Full Term Performance…………………………………………………………………………….6 2.3 Management Agreement with Professional Corporation – Non-Licensed Franchisees…………...6 2.4 |
|
| September 26, 2023 |
Form of the Registrant’s Regional Developer License Agreement. 10.24 THE JOINT CORP. REGIONAL DEVELOPER AGREEMENT Date of Agreement TABLE OF CONTENTS SECTION PAGE 1. GRANT OF RIGHTS………………………………………………………………………..…...1 2. REGIONAL DEVELOPER’S DEVELOPMENT OBLIGATION …………………................1 2.1 Minimum Development Obligations and Development Schedule ………...……….1 2.2 Regional Developer Sales Office and Opening …………………………..………..4 3. TERRITORIAL RIGHTS AND LIMITATIO |
|
| September 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1 to Form 10-K) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00 |
|
| September 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| September 26, 2023 |
Fourth Amended and Restated Bylaws FOURTH AMENDED AND RESTATED Ex. 3.2 BYLAWS OF THE JOINT CORP. ARTICLE I Meetings of Stockholders Section 1.1 Annual Meetings. If required by applicable law, an annual meeting of stockholders shall be held for the election of directors at such date, time and place, if any, either within or without the State of Delaware, as may be designated by resolution or resolutions of the Board of Directors (th |
|
| September 25, 2023 |
JYNT / Joint Corp / Bandera Partners LLC - AMENDMENT NO. 2 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 2)1 The Joint Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 47973J102 (CUSIP Number) JEFFERSON GRAMM BANDERA PARTNER |
|
| September 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): August 30, 2023 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) |
|
| September 15, 2023 |
JYNT / Joint Corp / Bandera Partners LLC - AMENDMENT NO. 1 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 The Joint Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 47973J102 (CUSIP Number) JEFFERSON GRAMM BANDERA PARTNER |
|
| September 13, 2023 |
EXHIBIT 99.1 The Joint Corp. Reports Preliminary Second Quarter 2023 Financial Results - Grew Q2 2023 Preliminary Revenue 18% and Preliminary Adjusted EBITDA 23% vs. Q2 2022 - - Evaluating Programs to Cull Approximately 10% of the Corporate Portfolio - SCOTTSDALE, Ariz., Sept. 13, 2023 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic c |
|
| September 13, 2023 |
Exhibit 99.2 Preliminary Q2 2023 Investor Presentation As of June 30, 2023 | Reported on September 13, 2023 The Joint Corp. | NASDAQ: JYNT | thejoint.com Safe Harbor Statements © 2023 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements” about future events and expectations. Forward - looking statements are based on our beliefs, |
|
| September 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2023 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| September 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): September 6, 2023 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation (Commission file n |
|
| September 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2023 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| September 6, 2023 |
The Joint Corp. Provides Updates on the June 30, 2023 SEC 10-Q Filing EXHIBIT 99.1 The Joint Corp. Provides Updates on the June 30, 2023 SEC 10-Q Filing SCOTTSDALE, Ariz., Sept. 06, 2023 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced the company intends to restate previously issued audited financial statements as of and for the year ending December 31, 2022 contained in the Annual Re |
|
| August 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2023 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| August 25, 2023 |
The Joint Corp. Announces Receipt of Delinquency Notification Letter from Nasdaq EXHIBIT 99.1 The Joint Corp. Announces Receipt of Delinquency Notification Letter from Nasdaq SCOTTSDALE, Ariz., Aug. 25, 2023 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced it received a delinquency notification letter from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) on |
|
| August 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 001-36724 CUSIP Number: 47973J102 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| August 11, 2023 |
JYNT / Joint Corp / Bandera Partners LLC - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. )1 The Joint Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 47973J102 (CUSIP Number) JEFFERSON GRAMM BANDERA PARTNERS |
|
| August 11, 2023 |
Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the shares of Common Stock, $0.001 par value per share, of The Joint Corp. This Joint Filing Agreement shall be fi |
|
| August 10, 2023 |
EXHIBIT 99.2 Q2 2023 Operating Highlights As of June 30, 2023 | Reported on August 10, 2023 The Joint Corp. | NASDAQ: JYNT | thejoint.com 2 © 2023 The Joint Corp. All Rights Reserved. Safe Harbor Statements Certain statements contained in this presentation are "forward - looking statements” about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and |
|
| August 10, 2023 |
EXHIBIT 99.1 The Joint Corp. Reports Second Quarter 2023 Operating Highlights – System-wide Sales Grew 13% to $120.1 Million – – Unrestricted Cash $13.6 Million at June 30, 2023, Compared to $9.7 Million at December 31, 2022 – – Increased Clinics to 890 at June 30, 2023 and Achieved the 900 Clinic Milestone in August 2023 – SCOTTSDALE, Ariz., Aug. 10, 2023 (GLOBE NEWSWIRE) - The Joint Corp. (NASDA |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2023 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 25, 2023 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) (Commission file numbe |
|
| May 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 The Joint Corp. |
|
| May 25, 2023 |
The Joint Corp. Amended and Restated 2014 Incentive Stock Plan, as amended Exhibit 99.1 Amendment to The Joint Corp. Amended and Restated 2014 Incentive Stock Plan The first sentence of Section 4.3, Maximum Number of Shares, of the Amended and Restated 2014 Incentive Stock Plan, as amended (the “Plan”), is hereby deleted in its entirety and replaced with the following: The maximum total number of shares of common stock for which Awards may be granted under this Plan is 3 |
|
| May 25, 2023 |
Exhibit 107 Calculation of Filing Fee Table S-8 (Form Type) The Joint Corp. (Exact Name of Registrant as Specified in its Charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price (2) Fee Rate Amount of Registration Fee Equity Common Stock, par value $.00 |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| May 5, 2023 |
Executive Short-Term Incentive Plan (amended March 7, 2023). 10.16 The Joint Corp. Executive Short-Term Incentive Plan (STIP) (Amended March 7, 2023) Plan Overview The Joint Corp. (“the Company”) Executive Short-Term Incentive Plan (“Executive STIP”) is an annual bonus plan. The STIP pool earned for each year will be determined based upon the achievement of the Company’s Target EBITDA for that year. Upon achievement of the Target EBITDA for the calendar yea |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| May 4, 2023 |
Exhibit 99.2 Q1 2023 Financial Results As of March 31, 2023 | Reported on May 4, 2023 The Joint Corp. | NASDAQ: JYNT | thejoint.com 2 © 2023 The Joint Corp. All Rights Reserved. Safe Harbor Statements Certain statements contained in this presentation are "forward - looking statements” about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and expec |
|
| May 4, 2023 |
EXHIBIT 99.1 The Joint Corp. Reports First Quarter 2023 Financial Results - Grew Q1 2023 Revenue 27%, System-wide Sales 17% and System-wide Comp Sales 8% vs. Q1 2022 - - Increased Clinic Count to 870, Including 130 Company-Owned or Managed Clinics, at March 31, 2023 - SCOTTSDALE, Ariz., May 04, 2023 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of |
|
| April 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 20, 2023 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) (Commission file num |
|
| April 26, 2023 |
Exhibit 3.2 Third Amended and Restated Bylaws of The Joint Corp. (Amended and Restated as of April 20, 2023) Table of Contents Article 1 Offices 4 1.1 Registered Office 4 1.2 Other Offices 4 Article 2 Stockholders 4 2.1 Annual Meeting 4 2.2 Business at Annual Meetings of Stockholders 4 2.3 Proxy Access for Director Nominations 6 2.4 Special Meetings 12 2.5 Place of Meetings 13 2.6 Notice of Meetin |
|
| April 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| March 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2023 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| March 13, 2023 |
The Joint Corp. Thanks Retiring Board Member James H. Amos, Jr. EXHIBIT 99.1 The Joint Corp. Thanks Retiring Board Member James H. Amos, Jr. SCOTTSDALE, Ariz., March 13, 2023 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced James H. Amos, Jr. has notified the company that he will complete his term on May 25, 2023 and not stand for reelection at the company’s 2023 Annual Meeting o |
|
| March 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36724 The Joint Corp. (Exact na |
|
| March 10, 2023 |
Form of Registrant’s Franchise Agreement. 10.25 THE JOINT CORP. FRANCHISE AGREEMENT TABLE OF CONTENTS SECTION PAGE TOC \h \u \z 1. INTRODUCTION……………………………………………………………………………………4 2. GRANT OF FRANCHISE…………………………………………………………………………...5 2.1 Term; Reference to Exhibit 1………………………………………………………………………5 2.2 Full Term Performance…………………………………………………………………………….6 2.3 Management Agreement with Professional Corporation – Non-Licensed Franchisees…………...6 2.4 |
|
| March 10, 2023 |
Form of Registrant’s Regional Developer License Agreement. 10.24 THE JOINT CORP. REGIONAL DEVELOPER AGREEMENT Date of Agreement TABLE OF CONTENTS SECTION PAGE 1. GRANT OF RIGHTS………………………………………………………………………..…...1 2. REGIONAL DEVELOPER’S DEVELOPMENT OBLIGATION …………………................1 2.1 Minimum Development Obligations and Development Schedule ………...……….1 2.2 Regional Developer Sales Office and Opening …………………………..………..4 3. TERRITORIAL RIGHTS AND LIMITATIO |
|
| March 9, 2023 |
EXHIBIT 99.1 The Joint Corp. Reports Fourth Quarter and Year-end 2022 Financial Results - Grew Q4 2022 Revenue 26%, System-wide Sales 18%, and System-wide Comp Sales 8% vs. Q4 2021 - - Increased Clinic Count to 838 at Year-end 2022, Including 126 Company-Owned or Managed Clinics - SCOTTSDALE, Ariz., March 09, 2023 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and |
|
| March 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2023 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| March 9, 2023 |
Exhibit 99.2 Q4 2022 Financial Results As of December 31, 2022 | Reported on March 9, 2023 2 Safe Harbor Statements Certain statements contained in this presentation are "forward - looking statements” about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our gr |
|
| February 13, 2023 |
JYNT / Joint Corp / Bandera Partners LLC - AMENDMENT NO. 2 TO THE SCHEDULE 13G Passive Investment SC 13G/A 1 sc13ga208706jynt02132023.htm AMENDMENT NO. 2 TO THE SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2)1 The Joint Corp. (Name of Issuer) Common Stock, $0.001 par valu |
|
| February 9, 2023 |
JYNT / Joint Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Joint Corp. Title of Class of Securities: Common Stock CUSIP Number: 47973J102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13 |
|
| January 13, 2023 |
The Joint Corp. 16767 N. Perimeter Drive, Suite 110 Scottsdale, AZ 85260 January 13, 2023 CORRESP 1 filename1.htm The Joint Corp. 16767 N. Perimeter Drive, Suite 110 Scottsdale, AZ 85260 January 13, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, NE Washington, D.C. 20549-3561 Attention: Ameen Hamady or Kristi Marrone Re: The Joint Corp. Form 10-K for the year ended December 31, 2021 Filed March 1 |
|
| January 13, 2023 |
JYNT / Joint Corp / MILLENNIUM MANAGEMENT LLC Passive Investment SC 13G 1 JYNTSC13G.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 THE JOINT CORP. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 47973J102 (CUSIP Number) JANUARY 4, 2023 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The J |
|
| November 3, 2022 |
EXHIBIT 99.1 The Joint Corp. Reports Third Quarter 2022 Financial Results - Grew Revenue 27%, System-wide Sales 18%, and System-wide Comp Sales 6% vs. Q3 2021 - - Opened 38 Clinics, Up from 33 in Q3 2021 - Surpassed 800 Clinic Milestone, Closing Q3 2022 with 805 Clinics, Including 115 Company-Owned or Managed Clinics - SCOTTSDALE, Ariz., Nov. 03, 2022 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JY |
|
| November 3, 2022 |
EX-99.2 3 exh992.htm EXHIBIT 99.2 Exhibit 99.2 Q3 2022 Financial Results As of September 30 , 2022 | Reported on November 3, 2022 Safe Harbor Statements Certain statements contained in this presentation are "forward - looking statements” about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial |
|
| November 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2022 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| August 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| August 5, 2022 |
Ex. 10.1 ASSET AND FRANCHISE AGREEMENT PURCHASE AGREEMENT THIS ASSET AND FRANCHISE AGREEMENT PURCHASE AGREEMENT (?Agreement?) is made and entered into on the date last set forth below on the signature page (?Effective Date?), by and between The Joint Corp., a Delaware corporation (?TJC?), SJV Tempe Marketplace, LLC, an Arizona limited liability company (?TM?), Shakarian Joint Ventures, LLC, an Ari |
|
| August 4, 2022 |
Exhibit 99.2 Q2 2022 Financial Results As of June 30 , 2022 | Reported on August 4, 2022 Safe Harbor Statements Certain statements contained in this presentation are "forward - looking statements? about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth |
|
| August 4, 2022 |
EXHIBIT 99.1 The Joint Corp. Reports Second Quarter 2022 Financial Results - Grew Revenue 24%, System-wide Sales 21%, and System-wide Comp Sales 8% vs. Q2 2021 - - Opened 34 Clinics, Bringing Total Clinics to 769 - - Sold 24 Franchise Licenses, Bringing the Year-to-Date Total to 46 - SCOTTSDALE, Ariz., Aug. 04, 2022 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager, a |
|
| August 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2022 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| June 10, 2022 |
JYNT / Joint Corp / ALGER ASSOCIATES INC - THE JOINT CORP. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* The Joint Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 47973J102 (CUSIP Number) May 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| May 31, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 26, 2022 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other juris- (Commission file (IRS employer diction of inco |
|
| May 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2022 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| May 23, 2022 |
EXHIBIT 99.1 The Joint Corp. Acquires Four Previously Owned Franchised Clinics, Strengthening the Scottsdale/Phoenix Region Cluster - Expected to be immediately accretive to the bottom line and improve the corporate clinic operating margin - SCOTTSDALE, Ariz., May 23, 2022 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chirop |
|
| May 10, 2022 |
JYNT / Joint Corp / Bandera Partners LLC - AMENDMENT NO. 1 TO THE SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1)1 The Joint Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 47973J102 (CUSIP Number) May 6, 2022 (Date |
|
| May 6, 2022 |
EX-10.1 2 exhibit101.htm EX-10.1 10.1 EXECUTION VERSION SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made as of February 28, 2022 (the “Second Amendment Effective Date”), by and among THE JOINT CORP., a Delaware corporation (“Borrower”), the other Loan Parties party hereto (“Loan Parties”), the Lenders party hereto (the “Lenders”), and JPMORG |
|
| May 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2022 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| May 5, 2022 |
Exhibit 99.2 Q1 2022 Financial Results As of March 31, 2022 | Reported on May 5, 2022 Safe Harbor Statements Certain statements contained in this presentation are "forward - looking statements? about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth pl |
|
| May 5, 2022 |
EXHIBIT 99.1 The Joint Corp. Reports First Quarter 2022 Financial Results - Grew Revenue 28%, System-wide Sales 27%, and System-wide Comp Sales 15%, Versus Q1 2021 - - Opened 31 Clinics, Including 27 Franchised - the Most for a First Quarter in the Company?s History - - Achieved Milestone of 100 Corporate Portfolio Clinics, Bringing Total Clinics to 736 - SCOTTSDALE, Ariz., May 05, 2022 (GLOBE NEW |
|
| April 22, 2022 |
DEF 14A 1 def14a041922.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| March 14, 2022 |
Amendment to Amended and Restated 2014 Incentive Stock Plan 10.5 Amendment to The Joint Corp. Amended and Restated 2014 Incentive Stock Plan (effective with respect to Awards issued on or after November 2, 2021) 1.The following shall be added to Article 2 of the Amended and Restated 2014 Incentive Stock Plan, as amended (the ?Plan?), immediately following the definition of ?SAR Award?: Section 16 Officer means an ?officer? as defined by Rule 16a-1 promulga |
|
| March 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36724 The Joint Corp. (Exact na |
|
| March 14, 2022 |
Form of Registrant’s Regional Developer Franchise Disclosure Document - 2021 THE JOINT ? ? RD FDD 2021 FRANCHISE DISCLOSURE DOCUMENT The Joint Corp. 16767 N. Perimeter Dr., Suite 110 Scottsdale, Arizona 85260 Telephone (480) 245-5960 Website: www.thejoint.com Email: [email protected] This disclosure document is for the right to own and operate a Regional Developer Business in which you will be responsible for promoting, establishing and supporting Location Franchises |
|
| March 14, 2022 |
Form of Registrant’s Unit Franchise Disclosure Document - 2021 {WS087179v1 } 1 FRANCHISE DISCLOSURE DOCUMENT The Joint Corp. 16767 N. Perimeter Dr., Suite 110 Scottsdale, Arizona 85260 Telephone (480) 245-5960 Website: www.thejoint.com Email: [email protected] This disclosure document is for the right to own and operate a franchise (?Location Franchise?) in which you will be responsible for operating and/or managing chiropractic clinics (?Clinic(s)?) th |
|
| March 11, 2022 |
JYNT / Joint Corp / Bandera Partners LLC - THE SCHEDULE 13G Passive Investment SC 13G 1 sc13g0870600203112022.htm THE SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )1 The Joint Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Secu |
|
| March 11, 2022 |
Exhibit 99.1 Joint Filing Agreement The undersigned hereby agree that the Statement on Schedule 13G dated March 11, 2022 with respect to the Common Stock, $0.001 par value, of The Joint Corp, and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Secur |
|
| March 10, 2022 |
JYNT / Joint Corp / ALGER ASSOCIATES INC - THE JOINT CORP. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* The Joint Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 47973J102 (CUSIP Number) February 28, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| March 4, 2022 |
Exhibit 10.1 E X E CU T I ON V E R S I ON SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this ?Amendment? ) is made as of February 28 , 2020 (the ?Second Amendment Effective Date? ), by and among THE JOINT CORP . , a Delaware corporation ( ?Borrower? ), the other Loan Parties party hereto (? Loan Parties ?), the Lenders party hereto (the ? Lenders ?), and JPMORGAN |
|
| March 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 28, 2022 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) (Commission file |
|
| March 4, 2022 |
Amended and Restated Revolving Loan Note dated February 28, 2022 Exhibit 10.2 EXECUTION VERSION REVOLVING LOAN NOTE $20,000,000 Chicago, Illinois February 28, 2022 FOR VALUE RECEIVED, the undersigned THE JOINT CORP., a Delaware corporation (herein, together with its successors and assigns, the ?Borrower?), hereby promises to pay to JPMORGAN CHASE BANK, N.A. (the ?Lender?) or its registered assignees, in lawful money of the United States of America and in immedi |
|
| March 2, 2022 |
NT 10-K 1 fnt10k030222.htm FORM NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 001-36724 CUSIP Number: 47973J102 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20- |
|
| February 25, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 24, 2022 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) (Commission fil |
|
| February 25, 2022 |
EXHIBIT 99.1 UPDATE - The Joint Corp. Reports Preliminary Fourth Quarter and Year-end 2021 Financial Results - Grows 2021 Revenue 38%, System-wide Sales 39%, and System-wide Comp Sales 29%, Compared to 2020 - - Sold 156 Franchise Licenses, Compared to 121 in 2020 - - Opened 130 Clinics, Including 20 Greenfields, Bringing the Total Corporate Count to 96 at Year End - SCOTTSDALE, Ariz., Feb. 24, 202 |
|
| February 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2022 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| February 24, 2022 |
EXHIBIT 99.2 ? 2022 The Joint Corp. All Rights Reserved. 1 Q4 2021 Preliminary Financial Results As of December 31, 2021 | Reported on February 24, 2022 Safe Harbor Statement ? 2022 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements? about future events and expectations. Forward - looking statements are based on our beliefs, a |
|
| February 24, 2022 |
EXHIBIT 99.1 The Joint Corp. Reports Preliminary Fourth Quarter and Year-end 2021 Financial Results - Grows 2021 Revenue 38%, System-wide Sales 39%, and System-wide Comp Sales 29%, Compared to 2020 - - Sold 156 Franchise Licenses, Compared to 121 in 2020 - - Opened 130 Clinics, Including 20 Greenfields, Bringing the Total Corporate Count to 96 at Year End - SCOTTSDALE, Ariz., Feb. 24, 2022 (GLOBE |
|
| February 14, 2022 |
EXHIBIT 1: Joint Filing Agreement (filed herewith): SW Investment Management LLC SC 13G/A EXHIBIT 1 JOINT ACQUISITION STATEMENT The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. |
|
| February 14, 2022 |
JYNT / Joint Corp / SW Investment Management LLC - AMENDMENT TO FORM SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* The Joint Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 47973J102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 14, 2022 |
JYNT / Joint Corp / Bandera Partners LLC - AMENDMENT NO. 5 TO THE SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 5)1 The Joint Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 47973J102 (CUSIP Number) December 31, 2021 |
|
| February 14, 2022 |
JYNT / Joint Corp / ALGER ASSOCIATES INC - THE JOINT CORP. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* The Joint Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 47973J102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| February 10, 2022 |
JYNT / Joint Corp / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SC 13G 1 tv01230-jointcorp.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Joint Corp. Title of Class of Securities: Common Stock CUSIP Number: 47973J102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Sche |
|
| November 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The J |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2021 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| November 4, 2021 |
EX-99.2 3 exh992.htm PRESENTATION Exhibit 99.2 © 2021 The Joint Corp. All Rights Reserved. 1 Q3 2021 Financial Results As of September 30, 2021 | Reported on November 4, 2021 Safe Harbor Statement © 2021 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements” about future events and expectations. Forward - looking statements are b |
|
| November 4, 2021 |
EXHIBIT 99.1 The Joint Corp. Reports Third Quarter 2021 Financial Results - Grows Revenue 36%, System-wide Sales 37%, and System-wide Comp Sales 27%, Compared to Q3 2020 - - Sold 44 Franchise Licenses, Compared to 30 in Q3 2020 - - Opened 33 Clinics, Including 5 Greenfields, Bringing the Total Corporate Count to 83 at Quarter End - - Raised 2021 Guidance on Franchise Openings, Revenue and Adjusted |
|
| October 8, 2021 |
JYNT / Joint Corp / ALGER ASSOCIATES INC - THE JOINT CORP. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* The Joint Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 47973J102 (CUSIP Number) September 30, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedu |
|
| August 6, 2021 |
Executive Short-Term Incentive Plan (amended May 2, 2021). The Joint Corp. Executive Short-Term Incentive Plan (STIP) (Amended May 2, 2021) Plan Overview The Joint Corp. (?the Company?) Executive Short-Term Incentive Plan (?Executive STIP?) is an annual bonus plan. The STIP pool earned for each year will be determined based upon the achievement of the Company?s Target EBITDA for that year. Upon achievement of the Target EBITDA for the calendar year, each |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| August 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2021 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| August 5, 2021 |
Exhibit 99.2 ? 2021 The Joint Corp. All Rights Reserved. 1 Q2 2021 Financial Results As of June 30, 2021 | Reported on August 5, 2021 Safe Harbor Statement ? 2021 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements? about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and expe |
|
| August 5, 2021 |
EXHIBIT 99.1 The Joint Corp. Reports Second Quarter 2021 Record Financial Results, Raises All Elements of Guidance - Grows Revenue 61%, System-wide Sales 64%, and System-wide Comp Sales 53%, Compared to Q2 2020 - - Reports Operating Income of $2.0 Million, Up 687% Compared to Q2 2020 - - Posts Adjusted EBITDA of $3.8 Million, Up 237% Compared to Q2 2020 - SCOTTSDALE, Ariz., Aug. 05, 2021 (GLOBE NE |
|
| July 9, 2021 |
JYNT / Joint Corp / ALGER ASSOCIATES INC - THE JOINT CORP. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* The Joint Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 47973J102 (CUSIP Number) June 30, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| June 17, 2021 |
JYNT / Joint Corp / Bandera Partners LLC - AMENDMENT NO. 4 TO THE SCHEDULE 13G Passive Investment SC 13G/A 1 sc13ga40870600206172021.htm AMENDMENT NO. 4 TO THE SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 4)1 The Joint Corp. (Name of Issuer) Common Stock, $0.001 par value |
|
| June 2, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 28, 2021 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) (Commission file numbe |
|
| May 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 3, 2021 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) (Commission file number |
|
| May 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| May 6, 2021 |
EXHIBIT 99.1 The Joint Corp. Reports First Quarter 2021 Financial Results - Grows Revenue 29%, System-wide Sales 28%, and System-wide Comp Sales 21%, Compared to Q1 2020 - - Reports Operating Income of $2.0 Million, Up 162% Compared to Q1 2020 - - Posts Adjusted EBITDA of $3.5 Million, Up 108% Compared to Q1 2020 - - Raises 2021 Revenue and Adjusted EBITDA Guidance - SCOTTSDALE, Ariz., May 06, 202 |
|
| May 6, 2021 |
EXHIBIT 99.2 ? 2021 The Joint Corp. All Rights Reserved. 1 Q1 2021 Financial Results As of March 31, 2021 | Reported on May 6, 2021 Safe Harbor Statement ? 2021 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements? about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and expect |
|
| May 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2021 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| April 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| April 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 15, 2021 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) (Commission file num |
|
| March 30, 2021 |
Letter from Plante & Moran, PLLC, dated as of March 30, 2021 Exhibit 16.1 March 30, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by The Joint Corp. and are in agreement with the statements contained in Item 4.01(a) therein, which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01(a) of Form 8-K of The Joint Corp. dated March 30, 202 |
|
| March 30, 2021 |
Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): March 29, 2021 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other jurisdiction of incorporation) (Commission file num |
|
| March 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36724 The Joint Corp. (Exact na |
|
| March 5, 2021 |
10.40 North Carolina Regional Developer License Purchase Agreement This North Carolina Regional Developer License Purchase Agreement (this ?Agreement?) is entered into on the date last set forth below on the signature page (the ?Effective Date?), by and between The Joint Corp., a Delaware corporation (?TJC?), Wellness Incorporated, a North Carolina corporation (?Seller?), and Paul Trindel (?Guaran |
|
| March 5, 2021 |
10.41 Georgia Regional Developer License Purchase Agreement This Georgia Regional Developer License Purchase Agreement (this ?Agreement?) is entered into on January 1, 2021 (the ?Effective Date?), by and between The Joint Corp., a Delaware corporation (?TJC?), Midtown Health Solutions, Inc., a Georgia corporation (?Seller?), and Dr. Patrick Greco (?Guarantor?). TJC, Seller and Guarantor are at tim |
|
| March 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2021 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| March 4, 2021 |
Exhibit 99.2 ? 2021 The Joint Corp. All Rights Reserved. 1 Q4 2020 Financial Results As of December 31, 2020 | Reported on March 4, 2021 Safe Harbor Statement ? 2021 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements? about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and e |
|
| March 4, 2021 |
EXHIBIT 99.1 The Joint Corp. Reports Fourth Quarter and Full Year 2020 Financial Results - Grows Revenue 23% Quarterly and 21% Annually, Compared to 2019 - - Reports Record Annual Operating Income of $5.5 Million, Up 61% Compared to 2019 - - Posts Record Adjusted EBITDA of $9.1 Million, Up 47% Compared to 2019 - - Increases Total Clinic Count to 579, Opening 21 Clinics in Q4 2020, Compared to 25 i |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 3)1 The Joint Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 47973J102 (CUSIP Number) December 31, 2020 |
|
| February 12, 2021 |
Joint Filing Agreement (filed herewith): EX-1 2 ex-1.htm JOINT ACQUISITION STATEMENT SW Investment Management LLC SC 13G/A EXHIBIT 1 JOINT ACQUISITION STATEMENT The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filin |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* The Joint Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 47973J102 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* The Joint Corp. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 47973J102 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu |
|
| January 27, 2021 |
Exhibit 10.1 The Joint Corp. Executive Short-Term Incentive Plan (STIP) (Amended January 25, 2021) Plan Overview The Joint Corp. (“the Company”) Executive Short-Term Incentive Plan (“Executive STIP”) is an annual bonus plan. The STIP pool earned for each year will be determined based upon the achievement of the Company’s Target EBITDA for that year. Upon achievement of the Target EBITDA for the ca |
|
| January 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): January 25, 2021 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other juris- diction of incorporation) (Commission file |
|
| January 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2020 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| January 5, 2021 |
EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 The Joint Corp. Acquires Two Regional Developer Territories - Increases Margin Contribution to the Company – SCOTTSDALE, Ariz., Jan. 05, 2021 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, acquired for $2.4 million the regional developer (RD) territories in North Carolina and in |
|
| November 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The J |
|
| November 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2020 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| November 5, 2020 |
Exhibit 99.2 © 2020 The Joint Corp. All Rights Reserved. 1 Q3 2020 Financial Results As of September 30, 2020 | Reported on November 5, 2020 Safe Harbor Statement © 2020 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements." We have tried to identify these forward - look ing statements by using words such as "may," "might," " wi |
|
| November 5, 2020 |
EXHIBIT 99.1 The Joint Corp. Reports Third Quarter 2020 Financial Results - Grows Revenue 21%, Compared to Q3 2019 – - Reports Record Net Income of $1.6 Million, Up 160% Compared to Q3 2019 – - Posts Record Adjusted EBITDA of $2.6 Million, Up 84% Compared to Q3 2019 - - Increases Total Clinic Count to 560, Opening 22 Clinics in Q3 2020- - Sells 30 Franchise Licenses in Q3 2020, Up from 28 in Q3 20 |
|
| September 21, 2020 |
SC 13G 1 swim-sc13g090920.htm ACQUISITION OF BENEFICIAL OWNERSHIP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. 0)* The Joint Corp. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 47973J102 (CUSIP Number) September 9, 2020 (Date of Event Which Requires Filing of |
|
| August 10, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 29, 2020 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other juris- (Commission file (IRS empl |
|
| August 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| August 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 6, 2020 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| August 6, 2020 |
Exhibit 99.2 © 2020 The Joint Corp. All Rights Reserved. 1 Q2 2020 Financial Results As of June 30, 2020 | Reported on August 6, 2020 Safe Harbor Statement © 2020 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements." We have tried to identify these forward - look ing statements by using words such as "may," "might," " will," "e |
|
| August 6, 2020 |
EXHIBIT 99.1 The Joint Corp. Reports Second Quarter 2020 Financial Results - Grows Revenue 13%, Compared to Q2 2019 - - Increases Total Clinic Count to 539, Opening 13 Clinics in Q2 2020 - - Sells 11 Franchise Licenses in Q2 2020 - SCOTTSDALE, Ariz., Aug. 06, 2020 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, reported its fi |
|
| June 2, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 29, 2020 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other juris- (Commission file (IRS employer diction of inco |
|
| May 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36724 The Joint |
|
| May 7, 2020 |
EXHIBIT 99.1 The Joint Corp. Reports First Quarter 2020 Financial Results - Grows System-Wide Sales 24% and Comp Sales 15%, Compared to Q1 2019 - - Increases Total Clinic Count to 530 - - Sells 24 Franchise Licenses - SCOTTSDALE, Ariz., May 07, 2020 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, reported its financial results |
|
| May 7, 2020 |
EXHIBIT 99.2 © 2020 The Joint Corp. All Rights Reserved. 1 Q1 2020 Financial Results As of March 31, 2020 | Reported On May 7, 2020 Safe Harbor Statement © 2020 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements." We have tried to identify these forward - look ing statements by using words such as "may," "might," " will," "exp |
|
| May 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 7, 2020 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| April 24, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| April 15, 2020 |
Exhibit 10.1 NO TE Date 4/9/2020 Note Amount $ 2,727,970.00 Borrower The Joint Corporation Lender JPMorgan Chase Bank, N.A. 1. PROMISE TO PAY. Borrower promises to pay to the order of Lender the Note Amount, plus interest on the unpaid principal balance at the Note Rate, and all other amounts required by this Note. 2. DEFINITIONS. “CARES Act” means the Coronavirus Aid, Relief, and Economic Securit |
|
| April 15, 2020 |
8-K 1 f8k041520.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): April 9, 2020 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporati |
|
| April 15, 2020 |
EX-99.1 3 exh991.htm PRESS RELEASE EXHIBIT 99.1 The Joint Chiropractic Secures $2.7 Million Loan under CARES Act Paycheck Protection Program Provision To Host First Quarter 2020 Results Conference Call on Thursday, May 7th SCOTTSDALE, Ariz., April 15, 2020 (GLOBE NEWSWIRE) - The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it received a |
|
| March 20, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): March 18, 2020 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other juris- (Commission file (IRS employer diction of in |
|
| March 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2)1 The Joint Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 47973J102 (CUSIP Number) March 10, 2020 (Da |
|
| March 6, 2020 |
Amendment to Amended and Restated 2014 Incentive Stock Plan Exhibit 10.6 Amendment to The Joint Corp. Amended and Restated 2014 Incentive Stock Plan (effective with respect to Awards issued on or after March 3, 2020) 1.Article 8 of the Amended and Restated 2014 Incentive Stock Plan (the “Plan”) is hereby deleted in its entirety and replaced with the following, effective for Awards issued on or after March 3, 2020: Article 8Change of Control; Dissolution or |
|
| March 6, 2020 |
Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The Joint Corporation (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): common stock, par value $0.001 per share (the “common stock”). The common stock is listed on The NASDAQ C |
|
| March 6, 2020 |
Exhibit 10.32 March 3, 2020 (retroactive to January 1, 2020) Mr. Jacob L. Singleton Dear Jake: This letter agreement (this “Amendment”) amends and extends your Employment Letter Agreement dated November 6, 2018 (the Letter Agreement, as so amended, the “Current Agreement”) with respect to your at-will employment arrangement as CFO. All capitalized terms used and not expressly defined herein shall |
|
| March 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36724 The Joint Corp. (Exact na |
|
| March 6, 2020 |
2020 Amended Form of Restricted Stock Award Agreement under Amended and Restated 2014 Stock Plan Exhibit 10.16 [[FIRSTNAME]] [[MIDDLENAME]] [[LASTNAME]] Restricted Stock Award (The Joint Corp. Amended and Restated 2014 Incentive Stock Plan) Subject to the following terms, The Joint Corp., a Delaware corporation (the Company), grants to the following employee of the Company (Grantee), as of the following grant date (the Grant Date), the following number of restricted shares (the Restricted Sha |
|
| March 6, 2020 |
2020 Amended Form of Incentive Stock Option Agreement under Amended and Restated 2014 Stock Plan Exhibit 10.9 [[FIRSTNAME]] [[MIDDLENAME]] [[LASTNAME]] ISO Stock Option Agreement (Incentive Stock Option Granted Under The Joint Corp. Amended and Restated 2014 Incentive Stock Plan) Subject to the following terms, The Joint Corp., a Delaware corporation (the Company), grants to the following employee of the Company (Grantee), as of the following grant date (the Grant Date), an incentive stock op |
|
| March 6, 2020 |
Amended Form of Nonstatutory Stock Option Agreement under Amended and Restated 2014 Stock Plan Exhibit 10.12 [[FIRSTNAME]] [[MIDDLENAME]] [[LASTNAME]] NSO Stock Option Agreement (Nonstatutory Stock Option Granted Under The Joint Corp. Amended and Restated 2014 Incentive Stock Plan) Subject to the following terms, The Joint Corp., a Delaware corporation (the Company), grants to the following employee of the Company (Grantee), as of the following grant date (the Grant Date), an nonstatutory s |
|
| March 6, 2020 |
Exhibit 10.20 OFFICE LEASE AGREEMENT FOR TERRA VERDE AT SCOTTSDALE LANDING TERRA VERDE OWNER LLC, a Delaware limited liability company as Landlord and THE JOINT CORP., a Delaware corporation as Tenant Dated: May 17, 2019 (to be completed by Landlord upon Landlord’s execution of this Lease) 4824-0900-0329v5/27933-0139 OFFICE LEASE AGREEMENT THIS OFFICE LEASE AGREEMENT is made and entered into as of |
|
| March 5, 2020 |
EXHIBIT 99.1 The Joint Corp. Reports Fourth Quarter and Full Year 2019 Financial Results - Grows Annual System-Wide Sales 33% and Comp Sales 25%, Compared to 2018 - - Increases Annual Net Income to $3.3 Million, Compared to $147,000 in 2018 - - More than Doubles Adjusted EBITDA to $6.2 Million, Compared to $2.9 Million in 2018- - Increases Franchise Licenses Sales to 126, Compared to 99 in 2018- - |
|
| March 5, 2020 |
EXHIBIT 99.2 © 2019 The Joint Corp. All Rights Reserved. 1 Q4 2019 Financial Results As of December 31, 2019 | Reported On March 5, 2020 Safe Harbor Statement © 2020 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements." We have tried to identify these forward - look ing statements by using words such as "may," "might," " will," |
|
| March 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 3, 2020 The Joint Corp. (Exact Name of Registrant as Specified in Charter) Delaware 001-36724 90-0544160 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| March 3, 2020 |
Exhibit 10.2 EXECUTION VERSION PLEDGE AND SECURITY AGREEMENT THIS PLEDGE AND SECURITY AGREEMENT (as it may be amended, restated, supplemented or otherwise modified from time to time, this “Security Agreement”) is entered into as of February 28, 2020 by and among THE JOINT CORP., a Delaware corporation (the “Borrower”), and any additional entities which become parties to this Security Agreement by |
|
| March 3, 2020 |
Term A Loan Note dated February 28, 2020 Exhibit 10.3 EXECUTION VERSION TERM A LOAN NOTE $5,500,000 Chicago, Illinois February 28, 2020 FOR VALUE RECEIVED, the undersigned THE JOINT CORP., a Delaware corporation (herein, together with its successors and assigns, the “Borrower”), hereby promises to pay to JPMORGAN CHASE BANK, N.A. (the “Lender”) or its registered assignees, in lawful money of the United State of America and in immediately |
|
| March 3, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 28, 2020 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware 001-36724 90-0544160 (State or other juris- (Commission file (IRS employer diction of |
|
| March 3, 2020 |
Revolving Loan Note dated February 28, 2020 Exhibit 10.4 EXECUTION VERSION REVOLVING LOAN NOTE $2,000,000 Chicago, Illinois February 28, 2020 FOR VALUE RECEIVED, the undersigned THE JOINT CORP., a Delaware corporation (herein, together with its successors and assigns, the “Borrower”), hereby promises to pay to JPMORGAN CHASE BANK, N.A. (the “Lender”) or its registered assignees, in lawful money of the United States of America and in immedia |
|
| March 3, 2020 |
Exhibit 10.1 EXECUTION VERSION CREDIT AGREEMENT dated as of February 28, 2020 among THE JOINT CORP. The Lenders Party Hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent JPMORGAN CHASE BANK, N.A., as Sole Bookrunner and Sole Lead Arranger TABLE OF CONTENTS Page ARTICLE I. Definitions 1 SECTION 1.01. Defined Terms 1 SECTION 1.02. Classification of Loans and Borrowings. 28 SECTION 1.03. Te |
